RSV

BD Veritor™ Plus System

Respiratory Syncytial Virus (RSV) rapid antigen testing

 

Effectively test for RSV

Viral respiratory tract infections are responsible for widespread disease.¹ Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRI) in young children in both the developed and developing worlds²⁻³.

BD Veritor™ Plus System for RSV

The BD Veritor™ Plus System for Rapid Detection of RSV is a digital immunoassay (DIA) that qualitatively detects RSV fusion protein. There are two test kits available: the point of care test kit detects RSV fusion protein in infants and pediatric patients under the age of 6 years suspected of having RSV by their healthcare provider; the laboratory kit detects RSV fusion protein in patients up to 20 years of age who are suspected of having RSV by their healthcare provider.

The system offers one-button functionality for workflow flexibility, allowing health care providers to confidently use the Analyzer.  

Clock icon

Fast, reliable results in as few as 11 minutes⁴⁻⁵

BD Veritor Plus Analyzer icon

Two analysis options to optimize workflow

Rapid RSV test clinical performance data

RSV is a common virus, and can spread rapidly, especially among children²⁻³.

Comparison of BD Veritor™ System for Rapid Detection of RSV Test to viral cell culture.

 

In the chart below, data shows that, when compared to an accepted standard method, the BD Veritor™ System has a high Sensitivity rate (sensitivity measures the ability of the test to appropriately make a positive identification) and fewer false negatives⁴⁻⁵. In addition, data shows a high Specificity rate (specificity measures the ability of the test to properly identify the absence of the test target) and fewer false positives⁴⁻⁵.

Specimen Type: Nasopharyngeal Swab (NPS)⁴⁻⁵

88.4%

Sensitivity

(95% C.I 82.8-92.4%)
98.3%

Specificity

(95% C.I 96.8-99.7%)

Reference method : Viral Cell Culture

Sensitiivity : 88.4% (95% CI: 82.8-92.4%)

Specificity : 98.3% (95% CI: 96.8-99.1%)

Specimen Type: Nasal Wash
(NPWA)⁴⁻⁵

91.6%

Sensitivity

(95% C.I 86.3-94.9%)
94.5%

Specificity

(95% C.I 91.2-96.7%)

Reference method : Viral Cell Culture

Sensitiivity : 91.6% (95% C.I 86.3-94.9%)

Specificity : 94.5% (95% C.I 91.2-96.7%)

Summary of the performance of the BD Veritor™ System for Rapid Detection of RSV Test compared to viral cell culture by specimen type, all sites

NPS
VIRAL CELL CULTURE

BD Veritor TM

  P N Total
P 153 9 162
N 20 524 544
Total 173 533 706

NPWA
VIRAL CELL CULTURE

BD Veritor TM

  P N Total
P 152 15 167
N 14 259 273
Total 166 274 440

Explanation of Terms:  

Sensitivity: Ability of the test to properly identify the test target when it is present, compared to an accepted standard method (viral culture).

Specificity: Ability of the test to properly identify when the test target is not present, compared to an accepted standard method (viral culture).

P: Positive
N: Negative
C.I.: Confidence Interval

BD Veritor™ Plus System ordering

As your facility continues to provide valuable rapid diagnostic testing, you may need to reorder. Please click here for more information.

REFERENCES

  1. Vaccine Knowledge Project: http://vk.ovg.ox.ac.uk/rsv. Accessed December 19, 2018
  2. Nair, Harish et. al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010 May 1;375(9725):1500-2
  3. CDC: https://www.cdc.gov/rsv/about/symptoms.html
  4. BD Veritor System for Rapid Detection of Respiratory Syncytial Virus (RSV), [package insert], 8086098. Franklin Lakes, NJ: Becton, Dickinson and Company.
  5. BD Veritor System for Rapid Detection of Respiratory Syncytial Virus (RSV), laboratory kit [package insert], 8086100. Franklin Lakes, NJ: Becton, Dickinson and Company.